Effect of vitamin D receptor knockout on Cornea epithelium wound healing and tight junctions

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 8, 2014, Pages 5245-5251

  Elizondo, Rodolfo A ^a   Yin, Zhaohong ^b   Lu, Xiaowen ^a   Watsky, Mitchell A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Corneal epithelium; Tight junctions; Vitamin D; Wound healing

Indexed keywords

BACITRACIN; BUPRENORPHINE; NEOMYCIN; OCCLUDIN; POLYMYXIN; PROTEIN ZO1; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; DIET; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; WOUND HEALING;

CORNEAL EPITHELIUM; TIGHT JUNCTIONS; VITAMIN D; WOUND HEALING;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, CORNEAL; EPITHELIUM, CORNEAL; MICE, KNOCKOUT; OCCLUDIN; RECEPTORS, CALCITRIOL; TIGHT JUNCTIONS; WOUND HEALING; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84907663112     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13553     Document Type: Article

References (61)

1. Ban Y, Dota A, Cooper LJ, et al. Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res. 2003;76:663-669.
2. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 2003;4:225-236.
3. McCartney MD, Cantucrouch D. Rabbit corneal epithelial wound repair-tight junction reformation. Curr Eye Res. 1992;11:15-24.
4. Fanning AS, Anderson JM. The tight junction protein ZO-1 establishes a link between the actin cytoskeleton and components of the paracellular seal. J Biol Chem. 1998;273: 29745-29753.
5. Furuse M, Hirase T, Itoh M, et al. Occludin-a novel integral membrane-protein localizing at tight junctions. J Cell Biol. 1993;123:1777-1788.
6. Yi X, Wang Y, Yu FSX. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest Ophthalmol Vis Sci. 2000;41:4093-4100.
7. Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci. 2011;52:7359-7364.
8. Paz HB, Tisdale AS, Danjo Y, Spurr-Michaud SJ, Argueso P, Gipson IK. The role of calcium in mucin packaging within goblet cells. Exp Eye Res. 2003;77:69-75.
9. Kollenkirchen U, Fox J, Walters MR. Normocalcemia without hyperparathyroidism in vitamin-D-deficient rats. J Bone Miner Res. 1991;6:273-278.
10. Li YC, Amling M, Pirro AE, et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology. 1998;139:4391-4396.
11. Bikle DD. 1,25(OH)2D3-modulated calcium induced keratinocyte differentiation. J Investig Dermatol Symp Proc. 1996;1: 22-27.
12. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T. Regulation of terminal differentiation of cultured mouse epidermal-cells by 1-alpha,25-dihydroxyvitamin-D3. Endocrinology. 1983;113: 1950-1957.
13. Bikle DD, Nemanic MK, Gee E, Elias P. 1,25-dihydroxyvitamin-D3 production by human keratinocytes-kinetics and regulation. J Clin Invest. 1986;78:557-566.
14. Cianferotti L, Cox M, Skorija K, Demay MB. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci U S A. 2007;104:9428-9433.
15. Demay MB, MacDonald PN, Skorija K, Dowd DR, Cianferotti L, Cox M. Role of the vitamin D receptor in hair follicle biology. J Steroid Biochem Mol Biol. 2007;103:344-346.
16. Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347:80-89.
17. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z. Calcium-and vitamin Dregulated keratinocyte differentiation. Mol Cell Endocrinol. 2001;177:161-171.
18. Oda Y, Uchida Y, Moradian S, Crumrine D, Elias PM, Bikle DD. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol. 2009;129:1367-1378.
19. Schauber J, Dorschner RA, Coda AB, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007;117: 803-811.
20. Suzuki T, Sano Y, Kinoshita S. Effects of 1 alpha,25-dihydroxyvitamin D-3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci. 2000;41:154-158.
21. Zhang Y, Leung DYM, Goleva E. Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J Biol Chem. 2013;288:14544-14553.
22. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 1998;142: 117-127.
23. Rebsamen MC, Sun JX, Norman AW, Liao JK. 1 alpha,25-dihydroxyvitamin D-3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res. 2002;91:17-24.
24. Somjen D, Weisman Y, Kohen F, et al. 25-hydroxyvitamin D-3-1 alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111:1666-1671.
25. Wakasugi M, Noguchi T, Inoue M, et al. Vitamin-D3 stimulates the production of prostacyclin by vascular smooth-muscle cells. Prostaglandins. 1991;42:127-136.
26. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
27. Cross HS, Peterlik M, Reddy GS, Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D-3-1 alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol. 1997;62:21-28.
28. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684-700.
29. Eisman JA, Martin TJ, Macintyre I, Moseley JM. 1,25-Dihydroxyvitamin-D receptor in breast-cancer cells. Lancet. 1979;2:1335-1336.
30. Freake HC, Abeyasekera G, Iwasaki J, et al. Measurement of 1,25-dihydroxyvitamin-D3 receptors in breast-cancer and their relationship to biochemical and clinical indexes. Cancer Res. 1984;44:1677-1681.
31. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin-D. Am J Clin Nutr. 1991;54:S193-S201.
32. Kallay E, Bises G, Bajna E, et al. Colon-specific regulation of vitamin D hydroxylases-a possible approach for tumor prevention. Carcinogenesis. 2005;26:1581-1589.
33. Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res. 2012;14: 211.
34. Narvaez CJ, Zinser G, Welsh J. Functions of 1 alpha,25-dihydroxyvitamin D-3 in mammary gland: from normal development to breast cancer. Steroids. 2001;66:301-308.
35. van der Rhee H, Coebergh JW, de Vries E. Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev. 2009;18:458-475.
36. Bises G, Kallay E, Weiland T, et al. 25-hydroxyvitamin D-3-1 alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem. 2004;52:985-989.
37. Chirayath MV, Gajdzik L, Hulla W, Graf J, Cross HS, Peterlik M. Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in caco-2 cell cultures. Am J Physiol. 1998;274:G389-G396.
38. Janowsky EC, Lester GE, Weinberg CR, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999;2:283-291.
39. Suzuki T, Sano Y, Sotozono C, Kinoshita S. Regulatory effects of 1 alpha,25-dihydroxyvitamin D-3 on cytokine production by human corneal epithelial cells. Curr Eye Res. 2000;20:127-130.
40. Xue ML, Zhu H, Thakur A, Willcox M. 1 alpha,25-Dihydroxyvitamin D-3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol. 2002;80: 340-345.
41. Lin Y, Ubels JL, Schotanus MP, et al. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and UV-B irradiation. Curr Eye Res. 2012;37:871-878.
42. Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci. 2011;52:7359-7364.
43. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol. 2001;280:H434-H440.
44. Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol. 1997;136:399-409.
45. Yu ASL, McCarthy KM, Francis SA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol. 2005;288:C1231-C1241.
46. Du D, Xu F, Yu L, et al. The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell. 2010;18:52-63.
47. Shin K, Wang Q, Margolis B. PATJ regulates directional migration of mammalian epithelial cells. EMBO Rep. 2007;8: 158-164.
48. Shin K, Straight S, Margolis B. PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J Cell Biol. 2005;168:705-711.
49. Kuwabara H, Kokai Y, Kojima T, Takakuwa R, Mori M, Sawada N. Occludin regulates actin cytoskeleton in endothelial cells. Cell Struct Funct. 2001;26:109-116.
50. Fanning AS, Van Itallie C, Anderson JM. Zonula occludins (ZO)-1 and-2 regulate apical morphogenesis and zonula adherens (ZA) assembly in polarized MDCK cells. FASEB J. 2011;25.
51. Fanning AS, Van Itallie CM, Anderson JM. Zonula occludens-1 and-2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia. Mol Biol Cell. 2012;23: 577-590.
52. Rodgers LS, Beam MT, Anderson JM, Fanning AS. Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1. J Cell Sci. 2013; 126:1565-1575.
53. Chi C, Trinkaus-Randall V. New insights in wound response and repair of epithelium. J Cell Physiol. 2013;228:925-929.
54. Sung YJ, Sung ZL, Ho CL, et al. Intercellular calcium waves mediate preferential cell growth toward the wound edge in polarized hepatic cells. Exp Cell Res. 2003;287:209-218.
55. Leiper LJ, Walczysko P, Kucerova R, et al. The roles of calcium signaling and ERK1/2 phosphorylation in a Pax6(+/-) mouse model of epithelial wound-healing delay. BMC Biol. 2006;4:27.
56. Contreras RG, Miller JH, Zamora M, Gonzalezmariscal L, Cereijido M. Interaction of calcium with plasma-membrane of epithelial (MDCK) cells during junction formation. Am J Physiol. 1992;263:C313-C318.
57. Gonzalezmariscal L, Contreras RG, Bolivar JJ, Ponce A, Deramirez BC, Cereijido M. Role of calcium in tight junction formation between epithelial-cells. Am J Physiol. 1990;259: C978-C986.
58. Kruse FE. Stem-cells and corneal epithelial regeneration. Eye. 1994;8:170-183.
59. Huang AJW, Tseng SCG. Corneal epithelial wound-healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci. 1991;32:96-105.
60. Kruse FE, Tseng SCG. Retinoic acid regulates clonal growth and differentiation of cultured limbal and peripheral corneal epithelium. Invest Ophthalmol Vis Sci. 1994;35:2405-2420.
61. Kubota H, Chiba H, Takakuwa Y, et al. Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation. Exp Cell Res. 2001;263:163-172.